AAAAAA

   
Results: 1-3 |
Results: 3
PRECLINICAL EVALUATION OF AN IMPROVED FORMULATION OF HUMAN RECOMBINANT FVIII (KOGENATE-2) - TOXICOLOGY, PHARMACOLOGY, PHARMACOKINETICS, ANDNEOANTIGENICITY
Authors: KOWOLENKO M IRWIN R WROBLEWSKI V
Citation: M. Kowolenko et al., PRECLINICAL EVALUATION OF AN IMPROVED FORMULATION OF HUMAN RECOMBINANT FVIII (KOGENATE-2) - TOXICOLOGY, PHARMACOLOGY, PHARMACOKINETICS, ANDNEOANTIGENICITY, Thrombosis and haemostasis, 1997, pp. 2084-2084
DEVELOPMENT OF A PCR BASED METHOD FOR THE ANALYSIS OF THE MITOCHONDRIAL TOXICITY OF NUCLEOSIDE ANALOGS IN MYELOLYMPHOCYTIC CELL-LINES
Authors: ABBOTT M WARNER G KOWOLENKO M
Citation: M. Abbott et al., DEVELOPMENT OF A PCR BASED METHOD FOR THE ANALYSIS OF THE MITOCHONDRIAL TOXICITY OF NUCLEOSIDE ANALOGS IN MYELOLYMPHOCYTIC CELL-LINES, The Journal of immunology, 150(8), 1993, pp. 318-318
ASSESSMENT OF TOXICITY ASSOCIATED WITH ADMINISTRATION OF AN ANTIBODY-DRUG CONJUGATE
Authors: KOWOLENKO M MEZZA LE DAVIDSON TJ
Citation: M. Kowolenko et al., ASSESSMENT OF TOXICITY ASSOCIATED WITH ADMINISTRATION OF AN ANTIBODY-DRUG CONJUGATE, The Journal of immunology, 150(8), 1993, pp. 326-326
Risultati: 1-3 |